Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05065060

Parkinson Progression Marker Initiative Online (PPMI Online)

Parkinson Progression Marker Initiative Online (PPMI Online) is an observational study collecting participant reported information from people with and without Parkinson's disease (PD), for the goal of better understanding risk and predictive factors for PD.

PPMI Online is part of the broader Parkinson Progression Marker Initiative aimed at identifying markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Parkinson Disease Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Movement Disorders Nervous System Diseases Neurodegenerative Diseases Parkinsonian Disorders Synucleinopathies

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

UCSF Movement Disorders and Neuromodulation Center (MDNC)

San Francisco, California, 94143, United States

Location status: Recruiting

Location contact

UCSF

CONTACT

877-525-7764

About this study

PPMI is a broad program that is expanding the goals of the original PPMI study, and will include this PPMI Online protocol, as well the PPMI Clinical [NCT04477785], PPMI Remote, PPMI Digital protocols (with external regulatory oversight). All participants in PPMI may be asked to participate in one or all of these protocols and their enrollment in these studies may occur in varying order. PPMI participants may also be asked to participate in additional PPMI companion studies (as they are developed), which may only involve a subset of PPMI participants based on their cohort designation

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Parkinson Disease (PD) Participants:
  • Male or female age 18 years or older.
  • Has received a diagnosis of Parkinson's disease

Participants without PD:

  • Male or female age 18 years or older.
  • Has not received a diagnosis of Parkinson's disease

Treatment and study plan

observation

Other

Observation

Primary outcomes

  1. Unified Parkinson's Disease Rating Scale Ib & II

    Time frame: Baseline to 240 months

    Evaluates self-reported motor and nonmotor Parkinson's disease symptoms

Study contacts

Contact information is provided by the study sponsor or research team.

University of California, San Francisco

CONTACT

[email protected]

877-525-7764

Sponsors and collaborators

Lead sponsor

Michael J. Fox Foundation for Parkinson's Research

Other

Registry information

Official study title

Parkinson's Progression Markers Initiative Online Study (PPMI Online)

Important dates

Study start
2021
Primary completion
2041
Study completion
2041
First posted
Oct 1, 2021
Registry last updated
Nov 25, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.